Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Regeneron Pharmaceuticals (REGN)
Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 91,530,728
  • Shares Outstanding, K 108,947
  • Annual Sales, $ 12,173 M
  • Annual Income, $ 4,338 M
  • 60-Month Beta 0.14
  • Price/Sales 7.60
  • Price/Cash Flow 19.07
  • Price/Book 3.71
Trade REGN with:

Options Overview Details

View History
  • Implied Volatility 21.66% ( -0.48%)
  • Historical Volatility 19.36%
  • IV Percentile 4%
  • IV Rank 9.30%
  • IV High 36.60% on 03/20/23
  • IV Low 20.13% on 11/24/23
  • Put/Call Vol Ratio 1.00
  • Today's Volume 1,240
  • Volume Avg (30-Day) 1,816
  • Put/Call OI Ratio 1.22
  • Today's Open Interest 47,511
  • Open Int (30-Day) 46,985

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 23 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate 8.69
  • Number of Estimates 10
  • High Estimate 10.95
  • Low Estimate 6.29
  • Prior Year 10.96
  • Growth Rate Est. (year over year) -20.71%

Price Performance

See More
Period Period Low Period High Performance
1-Month
783.57 +7.22%
on 11/10/23
850.28 -1.19%
on 12/07/23
+17.35 (+2.11%)
since 11/08/23
3-Month
769.19 +9.22%
on 10/27/23
853.97 -1.62%
on 10/13/23
+9.45 (+1.14%)
since 09/08/23
52-Week
668.00 +25.77%
on 01/09/23
853.97 -1.62%
on 10/13/23
+74.72 (+9.76%)
since 12/08/22

Most Recent Stories

More News
Could Regeneron Pharmaceuticals Stock Help You Become a Millionaire?

Regeneron has been an excellent investment in recent years. Can that trend continue?

REGN : 840.14 (-1.06%)
You Don't Have to Pick a Winner in Gene-Editing. Do This Instead.

The gene-editing revolution is unfolding at a record pace. Still, risks abound, and picking individual stocks may not be the wisest approach.

CRSP : 64.54 (-8.08%)
BEAM : 26.40 (-8.17%)
CRBU : 5.81 (-2.35%)
EDIT : 10.51 (-3.58%)
NTLA : 29.02 (-2.55%)
PRME : 8.50 (-0.70%)
VERV : 12.79 (-0.93%)
LLY : 598.05 (+1.66%)
REGN : 840.14 (-1.06%)
VRTX : 350.15 (-1.07%)
ARKG : 28.60 (-0.38%)
HOOD : 11.73 (+2.18%)
2 Soaring Stocks to Buy and Hold

Both of these companies crushed earnings season.

REGN : 840.14 (-1.06%)
ROKU : 103.36 (+2.66%)
1 Supercharged Growth Stock That Could Make You a Millionaire in 10 Years

Biotech may be in a slump, but this innovator holds enormous promise as a potential wealth escalator.

PFE : 28.78 (+0.52%)
REGN : 840.14 (-1.06%)
NTLA : 29.02 (-2.55%)
Regeneron: Q3 Earnings Snapshot

Regeneron: Q3 Earnings Snapshot

REGN : 840.14 (-1.06%)
Regeneron Pharmaceuticals (REGN) Earnings Analysis -- Should Investors Brace for Impact?

Regeneron Pharmaceuticals (REGN) has an impressive revenue and earnings surprise history. So, as the company gears up to post its third-quarter report, is REGN the right pick? Read on... Regeneron...

GILD : 79.02 (+1.24%)
JAZZ : 120.42 (+0.73%)
OTSKY : 19.3500 (-1.93%)
REGN : 840.14 (-1.06%)
Gene Therapy Could Be On the Cusp of a Major Breakthrough, but Investors May Have to Remain Patient

This gene-editing pioneer could make history this week. But shareholders should remain focused on the long term.

REGN : 840.14 (-1.06%)
AMGN : 269.12 (-0.81%)
BLUE : 2.86 (-40.54%)
EDIT : 10.51 (-3.58%)
CRSP : 64.54 (-8.08%)
VRTX : 350.15 (-1.07%)
Stock-Split Watch: Could These 2 Growth Stocks Be Next?

Neither company has discussed it, at least not yet.

REGN : 840.14 (-1.06%)
BKNG : 3,275.00 (+1.13%)
Global Cancer Vaccines Market Share Is Expected To Reach $19.27 Billion By 2030

EQNX::TICKER_START (OTCPK:DTCFF),(CSE:DTC),(NASDAQ:JAZZ),(NASDAQ:EXEL),(NASDAQ:AMGN),(NASDAQ:REGN) EQNX::TICKER_END

DTCFF : 1.8500 (unch)
DTC.CN : 2.8000 (+27.27%)
JAZZ : 120.42 (+0.73%)
EXEL : 22.00 (+0.05%)
AMGN : 269.12 (-0.81%)
REGN : 840.14 (-1.06%)
Which Is the Better Long-Term Hold for Investors: Pfizer or Roche?

The venerable pharmaceutical companies' shares have slumped this year.

BMY : 50.31 (+0.30%)
SGEN : 218.98 (+0.30%)
REGN : 840.14 (-1.06%)
BNTX : 103.43 (+1.48%)
PFE : 28.78 (+0.52%)
RHHBY : 36.0000 (+1.18%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Regeneron is a biotechnology company focused on the discovery, development and commercialization of treatments targeting serious medical conditions. The company's portfolio boasts nine marketed drugs - Eylea, Dupixent, Praluent, Kevzara, Libtayo, Evkeeza, Inmazeb Arcalyst and Zaltrap. The company also...

See More

Key Turning Points

3rd Resistance Point 854.06
2nd Resistance Point 851.04
1st Resistance Point 845.59
Last Price 840.14
1st Support Level 837.12
2nd Support Level 834.10
3rd Support Level 828.65

See More

52-Week High 853.97
Last Price 840.14
Fibonacci 61.8% 782.93
Fibonacci 50% 760.98
Fibonacci 38.2% 739.04
52-Week Low 668.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar